DroneShield's Interim Report Looms as a Market Divided Between Record Backlog and Record Short Interest

DroneShield's order book hits record highs, but ASIC probe, CEO exits, and 15.1% short interest keep stock near 52-week lows ahead of Aug 26 results.

The Australian counter-drone specialist heads into its August 26 half-year results with an unusual distinction: its order book has never looked stronger, yet its stock has rarely been more distrusted.

DroneShield has locked in 206 million Australian dollars in committed revenue for fiscal 2026 as of end-July — roughly 95 percent of what the company generated in all of last year. July alone brought fresh European military contracts worth 23.2 million Australian dollars for its vehicle-mounted DSX systems. The newly unveiled RfRecon, a portable radio-frequency detection and direction-finding platform aimed at defense, government and security customers, is slated to start contributing to sales in the second half of 2026.

None of that is moving the needle much in the market's eyes. The shares were changing hands at 1.23 euros in recent trading, down 3.9 percent on the day and off 32 percent since the start of the year. The stock sits roughly 14 percent below its 50-day moving average of 1.44 euros and about 30 percent beneath its 200-day average. At 1.28 euros, it trades some 66 percent below the 52-week high of 3.79 euros reached in early October.

The ASIC investigation and a record short position

The overhang is partly regulatory. Australia's corporate watchdog ASIC continues to examine the company's disclosures and trading activity from November 2025. That probe, combined with intensifying competition in the counter-drone sector, has helped make DroneShield the most shorted stock on the Australian market, with short interest climbing to 15.1 percent.

Yet not every institutional player is heading for the exits. Citigroup Global Markets Australia disclosed a 5.6853 percent stake in early August following share purchases on August 5 — a counterweight to the bearish positioning in the options market, even if it doesn't resolve the underlying doubts.

Governance shake-up adds another layer of uncertainty

The leadership transition has compounded investor unease. CEO Oleg Vornik and Chairman Peter James both announced their departures in early April, triggering governance concerns that have lingered ever since. The market's reaction to the RfRecon unveiling — a modest gain of just over one percent — suggested investors were willing to acknowledge the product without embracing it.

Strong first half, tempered full-year guidance

The interim numbers themselves tell a story of rapid growth meeting cautious expectations. First-half revenue climbed 74 percent year-on-year to 125.8 million Australian dollars, yet management has guided to full-year growth of just 15 to 25 percent — a projection of 250 to 270 million Australian dollars that falls well short of what analysts had previously penciled in. That gap between the half-year momentum and the tempered outlook is likely to dominate the August 26 earnings call and the investor webinar scheduled for the following day.

A Bell Potter analyst maintained a buy recommendation at the end of July even after slashing the price target from 4.80 to 2.50 Australian dollars — a vote of confidence in the operational story, though one that predates several weeks of market turbulence.

A test of whether product news can translate into orders

The pivotal question for shareholders is straightforward: can RfRecon convert from announcement to signed contracts quickly enough to push committed revenue beyond the 206 million Australian dollars already secured and toward the upper end of the full-year range? Or will it remain another product launch without immediate sales impact?

The recent price action suggests nerves are still frayed. The stock swung from a loss of more than 13 percent in the prior week to a recovery of around 7 percent, with annualized 30-day volatility running at 74 percent. That kind of whipsawing leaves the shares acutely sensitive to any signal — positive or negative — from the upcoming report.

For now, the bull case rests on the strength of the backlog and the possibility that RfRecon accelerates order intake. The bear case points to unresolved governance questions and a market that has so far priced in skepticism rather than operational progress. The interim results will offer the clearest evidence yet on which side has the better argument.